Theranos Under Investigation by SEC, U.S. Attorney's Office
- Company says it was asked to provide documents, is cooperating
- Inquiries follow probes by federal, state health regulators
Theranos Adds SEC Investigation to Blood Test Scrutiny
This article is for subscribers only.
Theranos Inc. said it’s under investigation by the U.S. Securities and Exchange Commission and the U.S. Attorney’s Office for the Northern District of California, after the blood-testing startup has come under scrutiny by federal and state health regulators.
The criminal and civil investigations are among several probes described in a company memo provided to Bloomberg on Monday by closely held Theranos. The memo was sent to Theranos’s “partners,” which include Walgreens Boots Alliance Inc. and others.